In a significant breakthrough, researchers from Harvard Medical School have made an exciting discovery about lithium—a metal long known for its role in treating mood disorders. Traditionally, we associate lithium with bipolar disorder and depression. It has been a part of medical practice since before the FDA officially approved it in 1970.
New findings indicate that lithium isn’t just a mood stabilizer; it’s also vital for our brain health. Researchers have found that even small amounts of lithium are necessary for normal brain function, similar to vitamins and minerals like vitamin C and iron.
A recent study published in the journal Nature revealed that when researchers reduced lithium in the diets of mice, their brains exhibited signs of inflammation and aging. In particular, mice bred to model Alzheimer’s disease experienced accelerated memory loss and increased buildup of amyloid plaques, which are linked to the disease. Conversely, maintaining normal lithium levels seemed to protect these mice from Alzheimer’s-related changes as they aged.
Dr. Bruce Yankner, who led the study, suggested that this could pave the way for new treatments and diagnostic tools for Alzheimer’s, a condition affecting around 6.7 million older adults in the U.S., according to the CDC.
The research challenges previous assumptions about lithium’s role, suggesting it may serve as a common mechanism in brain degeneration leading to dementia. “The data are very intriguing,” Dr. Yankner noted, emphasizing the need for further research to understand the extent of lithium’s role.
In support of these findings, Dr. Ashley Bush, a neuroscientist at the University of Melbourne, commented that the evidence points to lithium having important physiological functions that might be impaired with age.
The study also examined how lithium interacts with beta amyloid plaques, which are known to obstruct normal brain function. Interestingly, it appears these plaques can bind to lithium, reducing its availability in the brain. When lithium is deficient, microglial cells—the brain’s waste management team—struggle to clean away beta amyloid, creating a harmful feedback loop.
Further exploration led researchers to test lithium orotate, a compound that does not bind to beta amyloid. When administered to Alzheimer’s model mice, lithium orotate demonstrated remarkable effects, reversing memory and thinking deficits and enabling the mice to navigate mazes again.
It’s essential to note that while lithium can be beneficial, higher doses used in clinical settings may lead to toxicity, particularly affecting the thyroid and kidneys. Still, the doses in this study were far lower, showing no harmful effects in the mice, although scientists caution against self-medicating with lithium supplements.
This research echoes past studies, like a 2017 Danish study indicating that people with higher lithium levels in drinking water were less likely to be diagnosed with dementia, and another 2022 UK study showing that lithium prescriptions were linked to reduced Alzheimer’s risk.
In conclusion, the potential role of lithium in brain health is a compelling area for future investigation. As Dr. Yankner stated, the connection between diet, lithium levels, and cognitive health opens many doors for understanding and potentially combating Alzheimer’s disease.
For more detailed insights, you can refer to the original research on Nature’s website.
